Eurofins Clinical Diagnostics DACH old

What Eurofins Clinical Diagnostics DACH old does

Eurofins Clinical Diagnostics DACH is the clinical diagnostics arm of Eurofins Scientific SE in Germany, operating a coordinated network of seven accredited laboratories across the country under the sub-brands Eurofins GeLaMed, Eurofins Humangenetik, Eurofins Pränatal-Medizin, and Eurofins LifeCodexx. The business delivers routine and specialty diagnostic services — laboratory medicine, microbiology, molecular diagnostics, human genetics, prenatal medicine, and hospital hygiene — to referring physicians, medical practices, hospitals, and clinics. Origins trace back to the 1902 Hygiene-Institut des Ruhrgebiets (founded on Robert Koch's recommendation), with the lab-medicine division joining Eurofins in July 2017; the network now employs approximately 650 highly qualified staff and processes roughly 12,000 samples daily at GeLaMed locations alone across more than 2,000 different examinations.

The portfolio combines classical clinical chemistry, hematology, immunology, microbiology, and serology with advanced molecular and genetic capabilities: PCR-based infection diagnostics, next-generation sequencing (NGS) panels, clinical and whole exome sequencing, Array-CGH, FISH, and the proprietary PraenaTest® non-invasive prenatal test (NIPT) — the first NIPT in Europe and Germany's first, which became a statutory health insurance (GKV) benefit in July 2022 and is offered alongside extensions PraenaRhD and PraenaGenom. Diagnostic hardware includes Abbott Alinity m fully automated molecular analyzers and two computer-aided laboratory lines. Quality is anchored in DIN EN ISO 15189 accreditation across all sites and DIN EN ISO/IEC 17025 for the Gelsenkirchen hospital hygiene department, with compliance to RiliBÄK and participation in ring trials.

The business model is B2B enterprise field sales: an outside sales force (Außendienst) and a digital Order Entry platform / LabApp drive test orders from medical professionals, with sample transport logistics linking practices and hospitals to the appropriate laboratory. Revenue is generated primarily as transaction fees billed to statutory (GKV) and private health insurers via the German EBM/GOÄ reimbursement framework, complemented by self-pay Individual Health Services (IGeL) such as the microRNA 371 testicular cancer test, preeclampsia screening, and extended PraenaGenom panels. Distribution is exclusively direct — no third-party resellers — across the seven-site German laboratory network, with the DACH brand positioning pointing to potential future expansion into Austria and Switzerland.

Name

Eurofins Clinical Diagnostics DACH old

Legal name

Eurofins Clinical Diagnostics DACH

Website

https://eurofins-clinical.de

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

Eurofins Clinical Diagnostics DACH operates seven accredited clinical laboratories across Germany providing laboratory medicine, human genetics, microbiology, molecular diagnostics, prenatal testing, and hospital hygiene to physicians and hospitals. It is part of Eurofins Scientific SE.

Ownership category

akta.pro rank

Product category

Clinical Laboratory Diagnostics

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Reference & Esoteric Testing Laboratories (HLAFAMAJ)

akta.pro secondary industry

Genetic & Prenatal Testing Laboratories (HLAFAMAH)

Keywords

• Clinical laboratory diagnostics
• Medical laboratory services
• Human genetics testing
• Prenatal diagnostics
• Hospital hygiene consulting

Headquarters

HQ city

Hamburg

HQ country

Germany

HQ region

Europe

Offices8 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

1. Clinical Diagnostic Laboratory Services: B2B laboratory testing services billed to statutory (GKV) and private health insurers, hospitals, and referring physicians. Revenue generated through German health insurance billing codes (EBM) and private payor agreements. Core revenue stream across lab medicine, microbiology, molecular diagnostics, and genetics.
2. Non-Invasive Prenatal Testing (NIPT / PraenaTest®): NIPT testing for trisomies, offered as a statutory health insurance benefit (since July 2022) and as an individual health service (IGeL/self-pay) for additional genomic panels (PraenaGenom).
3. IGeL (Individual Health Services): Self-pay diagnostic services not covered by statutory insurance, including allergy diagnostics, microRNA 371 test for testicular cancer, and preeclampsia testing.

Go-to-market motion1 record

Distribution channels5 records

Marketing channels7 records

Core offering

Eurofins Clinical Diagnostics DACH operates a network of seven clinical diagnostic laboratories across Germany providing laboratory medicine, human genetics, microbiology, molecular diagnostics, and hospital hygiene services to referring physicians and hospitals. The portfolio spans clinical chemistry, hematology, immunology, microbiology, oncology, serology, prenatal diagnostics (including the proprietary PraenaTest® NIPT), genetic sequencing, and hygiene inspections, billed primarily through the German statutory and private health insurance system.

Product overview

Eurofins Clinical Diagnostics DACH operates as a unified clinical diagnostic network offering laboratory medicine, human genetics, prenatal medicine, microbiology, molecular diagnostics, and hospital hygiene services. The portfolio includes core diagnostic brands (Eurofins Clinical Diagnostics DACH, Eurofins Humangenetik, Eurofins Pränatal-Medizin, Eurofins GeLaMed) and specific products like the PraenaTest® NIPT family (PraenaTest®, PraenaRhD, PraenaGenom). Seven laboratories across Germany are coordinated through the network, supported by Order Entry and LabApp systems for electronic test ordering and results delivery.

Differentiator

Problem solved

Functional benefit

Brands

• PraenaTest®: Non-invasive prenatal testing (NIPT) product for trisomy detection (13, 18, 21) - the first NIPT in Europe
• PraenaRhD
• PraenaGenom

Quantifiable outcome

• 12,000 samples processed daily across GeLaMed laboratories
• +3 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles3 records

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

One partnership is on record.

• Ärzte ohne Grenzen Deutschland (Médecins Sans Frontières)coreStrategic or Co-development Partner · 2 November 2023Eurofins Clinical Diagnostics DACH is an official cooperation partner of Ärzte ohne Grenzen Deutschland (Médecins Sans Frontières). The partnership focuses on supporting women's health projects. Additionally, Eurofins runs the 'Sie Senden Wir Spenden' campaign, donating 1 Euro for every Praena blood sample returned via Deutsche Post to support MSF projects.

Scale indicators9 records

Recent moves10 records

Expansion highlights7 records

Emerging players

• Centogene: Germany-based rare disease and genetic diagnostics company offering exome/genome sequencing, biomarker testing, and prenatal screening. Comparable in the human genetics/prenatal testing portfolio, with overlap in NIPT-adjacent offerings.
• CeGaT: German provider of genetic diagnostics (NGS panels, exome, whole genome) and NIPT services. Comparable in human genetics and NIPT product lines, particularly overlapping with PraenaTest and exome offerings, though more specialized.

Broad incumbents

• University Hospital Laboratories (e.g., UKB Bonn, Charité Berlin): Public/university hospital laboratories providing advanced clinical and genetic diagnostics with strong specialty and research capabilities. Comparable as established providers of reference/esoteric and genetic testing that compete for complex cases.
• Sonic Healthcare: Global medical diagnostics operator with German operations (Dr. Limbach, LADR-adjacent acquisitions). Comparable as a broader incumbent operating multi-site clinical labs in Germany with similar services.

Others

• Helios Hospital Group (Fresenius): Largest private hospital operator in Germany running in-house laboratories serving its hospital network. Comparable as a customer/competitor for hospital hygiene and clinical lab services, though the laboratory is captive rather than commercial.

Direct peers

• MVZ Labor Dr. Limbach (part of Sonic Healthcare): Major German medical laboratory network within Sonic Healthcare providing clinical diagnostics and specialty testing to physicians and hospitals. Comparable as a multi-site, full-service clinical lab competitor in the German market.
• Labor Berlin: Hospital-affiliated medical laboratory in Berlin providing clinical diagnostics, microbiology, and genetics to hospitals and referring physicians. Comparable in service breadth and German hospital/physician customer base.
• Synlab: Europe's largest medical diagnostics services provider with extensive German laboratory operations offering routine clinical lab, specialty, and genetic testing. Directly comparable in product scope (clinical chemistry, microbiology, genetics, hospital services) and customer base (physicians and hospitals), making it the most direct competitor.
• LADR Laborverbund Dr. Kramer & Kollegen: German network of medical laboratories serving physicians and hospitals with clinical chemistry, microbiology, immunology, and human genetics diagnostics. Closely comparable in scope and DACH-region physician-focused GTM.
• amedes Holding: European laboratory group with significant German operations offering clinical diagnostics, human genetics, and gynecology/prenatal testing. Directly comparable given shared focus on genetics and prenatal services in Germany.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks4 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/channel/UCzaQwE28HgsZZ9XlDd1WM-g
• LinkedInlinkedin.com/company/eurofins-clinical-diagnostics-dach-old

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Eurofins Clinical Diagnostics DACH old